VNDA) (āVandaā or the āCompanyā) holding over 200,000 shares of the Companyās common stock, announced today that they have delivered a letter to independent members of the Board of Directors of ...
Vanda Pharmaceuticals Inc (NASDAQ:VNDA) concluded the trading at $4.28 Wednesday, April 10, with a fall of -1.83% from its closing price on previous day.
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the Supreme Court denied Vanda's petition for a writ of certiorari in its HETLIOZ® Abbreviated New Drug Application litigation ...
The Rights Plan, expiring on April 16, 2025, intends to protect the rights of all current and future stockholders by blocking any entity, person or group from acquiring Vanda without paying an ...